Medical and pharmaceutical giant Johnson & Johnson is opening a dedicated 3D bioprinting lab at Ireland’s Trinity College Dublin. The lab will occupy a 100-square-meter space at the university’s Biomedical Sciences Institute building.


The best research is often the result of public-private partnerships. With the financial muscle and global experience of Johnson & Johnson and the academic nous of Trinity College Dublin’s AMBER center, a new collaboration in Ireland looks set to make huge strides in 3D bioprinting research.


Johnson & Johnson, which has previously worked with 3D printing company Carbon and biotech company Aspect Biosystems, will establish its new 3D bioprinting laboratory in a 100-square-meter space at Trinity College Dublin’s Biomedical Sciences Institute building. There, the lab will be jointly led by AMBER’s Prof Daniel Kelly and Johnson & Johnson’s lead API and bioprinting researcher Joseph Ault.


The laboratory equipment will be made available to students and other principal investigators, though Johnson & Johnson will initially use the space to conduct research projects focused on orthopedics. In the longer term, the healthcare company will offer its internal scientific experts as adjunct professors.